The Biogen 2018 annual meeting is June 12. I voted AGAINST several directors and the pay package. Vote FOR the auditor and both shareholder proposals to enhance value. Biogen Inc. (BIIB) discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide. Most shareholders do not vote because reading through 80+ pages […]
Biogen Inc. (BIIB) discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It is one of the stocks in my portfolio. Their annual meeting is coming up on 6/10/2015. ProxyDemocracy.org had the vote of five funds (removed 2nd Calvert from table below, since it was duplicative) when I checked and voted […]
My wife and I don’t have the resources to or stock holdings to allow us to file 75 proxy access shareholder proposals, like New York City Comptroller Scott Stringer’s Boardroom Accountability Project. However, I have been writing about proxy access for 20 years and, together with Les Greenberg, filed the petition in 2002 with the […]
Sustainable capitalism, or is that even possible? David Harvey and Gar Alperovitz dig into the failure of capitalism, the hope presented by worker co-ops, and what activists fighting for a just economy must do to get there. You could say they are living in a dream-world, but isn’t it be a nice one? We can […]
Biogen Idec, $BIIB, is one of the stocks in my portfolio. Their annual meeting is June 12, 2014. ProxyDemocracy.org had collected the votes of four funds when I checked and voted on 6/10/2014. ProxyDemocracy.org now has collected the votes of five funds. I voted with management 46% of the time. View Proxy Statement. Read Warnings below. What follows are my recommendations on how to […]
Biogen Idec (BIIB) is one of the stocks in my portfolio. Their annual meeting is coming up on 6/12/2013. ProxyDemocracy.org had collected the votes of four funds when I checked on 6/8/2013. I voted with management 41% of the time. View Proxy Statement. (more…)
Biogen Idec (BIIB)($BIIB) is one of the stocks in my portfolio. Their annual meeting is coming up on 6/8/2012. Voting ends on 6/7 at Moxy Vote’s proxy voting platform, which had 6 recommendations “from good causes,” including 2 consolidations, when I checked and voted on 6/5. ProxyDemocracy.org had 6 funds voting. I voted (more…)